Archive · 29 Sep 2025
GSK CEO Walmsley Out, Miels In: New Leadership for Drug Giant
GSK, a large medicine company, is getting a new boss.
The current boss, Emma Walmsley, is leaving after almost nine years.
Luke Miels, who has been helping sell medicines for the company, will take over.
He was chosen to be the new boss after some thought.
Walmsley made changes to the company but the company's stock performance has been lacking.
Now Miels will focus on new medicines and boosting the stock price.
Some people think Miels has a good chance to do well.
Emma Walmsley is stepping down as CEO of GSK.
Luke Miels, the Chief Commercial Officer, will take over.
Miels joined GSK in 2017.
The change in leadership will take effect at the start of next year.
Miels's main challenges include delivering blockbuster drugs.
- Who
- Emma Walmsley is stepping down, and Luke Miels is taking over.
- What
- Change in CEO at GSK Plc.
- When
- Taking effect at the start of next year.
- Where
- At GSK Plc.
- Why
- Walmsley is stepping down; Miels was selected to replace her.
- Outgoing CEO
- Emma Walmsley
- Incoming CEO
- Luke Miels
- Miels' Previous Role
- Chief Commercial Officer
- Effective Date
- Start of next year
- Walmsley's Tenure
- Almost nine years
